Loading clinical trials...
Loading clinical trials...
A Randomized, Multicenter, Double-Masked, Parallel-Group Study Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Conditions
Interventions
BOL-303259-X
Timolol
+1 more
Locations
1
United States
Bausch & Lomb Inc.
Rochester, New York, United States
Start Date
January 1, 2013
Primary Completion Date
May 1, 2015
Completion Date
May 1, 2015
Last Updated
November 21, 2018
NCT07390890
NCT05902871
NCT07218796
NCT07119580
NCT07076303
NCT06865144
Lead Sponsor
Bausch & Lomb Incorporated
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions